Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for Emergence Delirium in Preschool Children
NCT04621305Phase 4Unknown
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- Nov 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remimazolam in emergence delirium (ED) (3 arms), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoint: Incidence of emergence delirium. Status: unknown.
02
Drugs
remimazolam
03
Conditions
emergence delirium (ED)
Beyond the preview
Go deeper on NCT04621305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04621305.